Skip to main content

Advertisement

You are viewing the new article page. Let us know what you think. Return to old version

LcrG secretion is not required for blocking of Yops secretion in Yersinia pestis

BMC Microbiologyvolume 8, Article number: 29 (2008) | Download Citation

Abstract

Background

LcrG, a negative regulator of the Yersinia type III secretion apparatus has been shown to be primarily a cytoplasmic protein, but is secreted at least in Y. pestis. LcrG secretion has not been functionally analyzed and the relevance of LcrG secretion on LcrG function is unknown.

Results

An LcrG-GAL4AD chimera, originally constructed for two-hybrid analyses to analyze LcrG protein interactions, appeared to be not secreted but the LcrG-GAL4AD chimera retained the ability to regulate Yops secretion. This result led to further investigation to determine the significance of LcrG secretion on LcrG function. Additional analyses including deletion and substitution mutations of amino acids 2–6 in the N-terminus of LcrG were constructed to analyze LcrG secretion and LcrG's ability to control secretion. Some changes to the N-terminus of LcrG were found to not affect LcrG's secretion or LcrG's secretion-controlling activity. However, substitution of poly-isoleucine in the N-terminus of LcrG did eliminate LcrG secretion but did not affect LcrG's secretion controlling activity.

Conclusion

These results indicate that secretion of LcrG, while observable and T3SS mediated, is not relevant for LcrG's ability to control secretion.

Background

Yersinia pestis contains a 75-kilobase (Kb) virulence plasmid called pCD1 that encodes the low calcium response (Lcr) regulon [1]. LcrG is a negative regulator of the Yersinia type three-secretion system (T3SS) that is thought to control secretion of the T3SS-secreted effectors [2], collectively termed Yops [1]. The Yersinia T3SS is activated by environmental signals [3]; in the presence of calcium, LcrG blocks secretion from the cytoplasm [4], and in the absence of calcium, LcrG is primarily located in the cytosol, with smaller amounts found in association with membranes and secreted into the culture supernatant [4]. LcrG binds another Yersinia regulatory protein, LcrV, to unblock secretion via LcrG-LcrV interaction [4]. According to the LcrG-titration model, in the presence of secretion-inducing conditions, LcrQ is exported, causing levels of LcrV to increase relative to the levels of LcrG. The excess LcrV titrates LcrG and relieves LcrG's secretion-blocking activity, possibly by removing LcrG from the secretion complex, which would allow full induction of the LCR and subsequent secretion of Yops [5, 6]. Based on the LcrG-titration model, LcrG secretion would not be necessary for LcrG function, accordingly this study addresses the significance of LcrG secretion to LcrG function in Y. pestis.

Signals that target Yops to the T3SS apparatus have been localized to the N-terminus of the Yops and to the mRNA [7–11]. However, neither the N-terminus of T3S-substrates nor the mRNA shares a consensus sequence, and the manner in which the T3SS can recognize diverse substrates is unclear [12–14]. Systematic mutagenesis of the presumed secretion signal in the N-terminus of YopE yielded mutants defective in Yop translocation but point mutants that abolished secretion were not identified [10]. Frameshift mutations that allowed the peptide sequences of these signals to remain intact also failed to prevent secretion. Suggesting that the signal that leads to secretion of Yops appears to be encoded in their mRNA rather than the peptide sequence [15]. In the case of YopQ, frameshift mutations were tolerated only when at least 13 codons of the T3SS signal sequence are present [15]. Mutations in the second codon of the secretion signal may abolish synthesis of YopQ, and mutations in the tenth codon may abolish secretion without affecting YopQ's synthesis [15].

In this study, we show that chimeric LcrG proteins with the GAL4 activation domain (from the GAL4 protein of Saccharomyces cerevisae [16]) fused to the N-terminus and the C-terminus of LcrG were not secreted intact. These non-secreted LcrG-GAL4AD chimeras appeared to transcomplement a ΔlcrG3 strain of Y. pesti s, demonstrating retention of LcrG function. This result was extended and confirmed by constructing deletion and substitution mutations affecting amino acids 2–6 in the N-terminus of LcrG. None of the LcrG mutants were affected for LcrG function. However, secretion of some of the functional mutant LcrGs could not be detected, suggesting that secretion of LcrG is not relevant for known LcrG functions.

Results and Discussion

LcrG was shown to be secreted into the growth medium in the absence of calcium when lcrG was initially characterized in Y. pestis [2]. Interestingly, secretion of LcrG by Y. enterocolitica is not detected [17]. Secretion of LcrG by Y. pseudotuberculosis is not examined in the literature, though secretion of LcrG by Y. pseudotuberculosis IP2666 was not detectable (data not shown). Reasons for LcrG secretion in Y. pestis and not the enteropathogenic yersinae are unknown and any suggestions at this point would be purely speculative. The secretion of LcrG by Y. pestis could possibly relate to the strength of LcrG interaction with LcrV. However, Lawton et al reported a very strong interaction between LcrG and LcrV in Y.pseudotuberculosis when they characterized residues in LcrV involved in LcrG interaction [5] and the LcrG-LcrV interaction has not been studied in that detail in Y. pestis or Y. enterocolitica. Changes in the sequence of LcrG are not likely to account for the difference in secretion as the Y. pestis and Y. pseudotuberculosis sequences are identical and the Y. enterocolitica sequences are 96–98% identical, therefore any differences in LcrG-LcrV interaction would likely be LcrV dependent. LcrG has been shown to be primarily a cytoplasmic protein in Y. pestis [4]. However, the exact site of LcrG function remains to be elucidated. In this study, the ability of LcrG to function when LcrG secretion was blocked was examined to test the hypothesis that LcrG secretion may not be required for LcrG function. In order to determine the effect of LcrG secretion on LcrG function, LcrG chimeras to the GAL4 AD domain and mutants affected in LcrG secretion were constructed and analyzed for the ability to regulate Yops secretion, we reasoned that the addition of GAL4 AD domain should block LcrG secretion. An LcrG chimera with GAL4AD fused to LcrG's N-terminus [(GAL4AD-LcrG) constructed for a previous study [18]] and a new LcrG chimera with GAL4AD fused to LcrG's C-terminus (LcrG-GAL4AD) were introduced into an lcrG deletion strain of Y. pestis (ΔlcrG3, [19]) and the ability of the chimeras to regulate Yops secretion and the secretion of GAL4AD-LcrG and LcrG-GAL4AD, themselves, was examined. Results demonstrated that both GAL4AD-LcrG and LcrG-GAL4AD could transcomplement a ΔlcrG3 strain of Y. pestis for growth (data not shown), Yops expression (Fig. 1A) and Yops secretion (Fig. 1B). Expression of GAL4AD-LcrG and LcrG-GAL4AD restored Ca2+-regulation of Yops as evidenced by the Ca2+-regulation of Yops B, D, E and LcrV (Fig. 1A) in the transcomplemeted ΔlcrG3 strains. The GAL4AD chimera also restored control of Yops secretion as seen in the silver stained gel of culture supernatants (Fig. 1B). Both of the chimeric LcrG proteins were expressed well (Fig. 2A), the GAL4-LcrG appeared to be degraded to yield free LcrG and the LcrG-GAL4AD had many degradation products (Fig. 2A), possibly including free LcrG. Additionally, the LcrG-GAL4AD fusion was readily secreted (Fig. 2B, lane 10) and the (Fig. 2A) GAL4AD-LcrG expressing strain appeared to secrete LcrG (Fig. 2B, lanes 7–8). The generation and secretion of free LcrG from the LcrG GAL4AD chimeras and the secretion of the LcrG-GAL4AD chimera limits the ability to draw conclusions from this set of experiments, since low levels of LcrG are reported to have observable function [6]. However, these results are suggestive that LcrG may be a type III secretion substrate and that LcrG secretion may not be necessary for LcrG function. In addition, the ability of the LcrG-GAL4AD to be secreted is reminiscent of studies with YopE fusions that allow secretion of fusion proteins fused to the C-terminus of YopE [20–22].

Figure 1
figure1

Transcomplementation of Y. pestis Δ lcrG3 with LcrG chimeras and N-terminal LcrG mutants. (A) Immunoblot detection of cellular LcrV, YopB, YopD, and YopE. Cells of Y. pestis, wild type (WT) containing plasmid pBAD18 (vector; lanes 1and 2), Y. pestis ΔLcrG3 containing plasmids pBAD18 (vector; lanes 3 and 4), pAraG18 (LcrG, lanes 5 and 6), pJM174 (GAL4AD-LcrG; lanes 7 and 8), pLR1 (LcrG-GAL4AD, lanes 9 and 10), pLR2 (LcrGd2-6, lanes 11 and 12), pLR3 (LcrGpS; lanes 13 and 14), pLR4 (LcrGpI, lanes 15 and 16), pLR5 (LcrGpSI, lanes 17 and 18) were separated by SDS-PAGE in a 10.5–14% gradient, 4–20% gradient or 12.5% polyacrylamide gels and immunoblotted. Immunoblots were probed with α-YopB (12.5% gel), α-YopD, α-YopE (10.5–14% gel) and α-LcrV (4–20% gel) primary antibodies. Proteins were visualized with alkaline-phosphatase conjugated secondary antibody and developed with NBT-BCIP. (B) Secreted proteins detected by silver staining. Culture supernatant proteins of Y. pestis; wild type (WT) (vector; lanes 1and 2), Y. pestis ΔLcrG3 containing plasmids pBAD18 (vector; lanes 3 and 4), pAraG18 (LcrG, lanes 5 and 6), pJM174 (GAL4AD-LcrG; lanes 7 and 8), pLR1 (LcrG-GAL4AD, lanes 9 and 10), pLR2 (LcrGd2-6, lanes 11 and 12), pLR3 (LcrGpS; lanes 13 and 14), pLR4 (LcrGpI, lanes 15 and 16, pLR5 (LcrGpSI, lanes 17 and 18) were separated by SDS-PAGE in a 12.5% polyacrylamide gel and detected by silver staining.

Full size image
Figure 2
figure2

LcrG secretion and expression by Y. pestis Δ lcrG3 with LcrG chimeras and N-terminal LcrG mutants. Whole cell and cell-free culture supernatants were separated by SDS-PAGE in a 4–20% or 10.5–14% gradient polyacrylamide gels. Proteins were analyzed by probing with α-LcrG (4–20% gradient polyacrylamide gel) and α-YopN, α-LcrH, α-SycN (10.5–14% gradient polyacrylamide gel). Proteins were visualized by probing with alkaline phosphatase conjugated secondary antibodies and developed with NBT-BCIP. (A) Whole cell fractions, Immunoblots: Lanes 1 and 2 Y. pestis (wild type, WT), Lanes 3 and 4 Y. pestis ΔlcrG3 pBAD18, Lanes 5 and 6 Y. pestis ΔlcrG3 pAraG18, Lanes 7 and 8, Y. pestis ΔlcrG3 GAL4AD-LcrG, Lanes 9 and 10 Y. pestis ΔlcrG3 LcrG-GAL4AD, Lanes 11 and 12 Y. pestis ΔlcrG3 LcrGd2-6, Lanes 13 and 14 Y. pestis ΔlcrG3 LcrGpS, Lanes 15 and 16 Y. pestis ΔlcrG3 LcrGpI, Lanes 17 and 18 Y. pestis ΔlcrG3 LcrGpSI. Identical immunoblots were prepared and probed separately with α-YopN, α-LcrH, α-LcrG or α-SycN, the blots were scanned and strips used to present the data to conserve space. (B) Culture supernatants: Lanes 1 and 2 Y. pestis (wild type, WT), Lanes 3 and 4 Y. pestis ΔlcrG3 pBAD18, Lanes 5 and 6 Y. pestis ΔlcrG3 pAraG18, Lanes 7 and 8, Y. pestis ΔlcrG3 GAL4AD-LcrG, Lanes 9 and 10 Y. pestis ΔlcrG3 LcrG-GAL4AD, Lanes 11 and 12 Y. pestis ΔlcrG3 LcrGd2-6, Lanes 13 and 14 Y. pestis ΔlcrG3 LcrGpS, Lanes 15 and 16 Y. pestis ΔlcrG3 LcrGpI, Lanes 17 and 18 Y. pestis ΔlcrG3 LcrGpSI. Identical immunoblots were prepared, one was probed with α-LcrG and the second was sequentially probed and developed with α-SycN, then α-LcrH, and finally with α-YopN.

Full size image

Because the results with the GAL4AD constructs were not satisfactory, a second method to disrupt LcrG secretion was sought to further examine the role of LcrG secretion on LcrG function. The N-terminus of the Yop effector proteins has been shown to have a signal for secretion in Yersinia [9–11, 22, 23] and the mRNA of Yops may also serve as a signal [15, 24, 25]. Since our LcrG constructs were being expressed on plasmid constructs separate from native upstream DNA, the ability of mRNA signals to influence LcrG secretion was not examined. Accordingly, published studies on the YopE N-terminal proteinaceous secretion signal [9–11] were used to guide our mutational manipulation of lcrG to eliminate LcrG secretion. Plasmids expressing various mutant LcrG proteins under control of the araBADp were constructed. The mutant LcrG proteins comprise; a deletion of aa 2–6 (LcrGd2-6), a replacement of amino acids 2–6 of LcrG with poly-serine (LcrGpS), poly-isoleucine (LcrGpI), or an amphipathic sequence consisting of alternating serine/isoleucine residues (LcrGpSI). The resulting mutant LcrG constructs expressing LcrGd2-6, LcrGpS, LcrGpI or LcrGpSI were transformed separately into a ΔlcrG3 strain of Y. pestis and analyzed for LcrG and Yops expression and secretion. Y. pestis ΔlcrG3 transcomplemented with LcrGd2-6, LcrGpS, LcrGpI or LcrGpSI expressing plasmids all changed from calcium blind growth to calcium dependent growth (data not shown). Importantly, the ΔlcrG3 strain of Y. pestis transcomplemented with LcrGd2-6, LcrGpS, LcrGpI or LcrGpSI had restored Ca2+ control of Yops expression (Fig. 1A) and Yops secretion (Fig. 1B) demonstrating LcrG function by the mutant LcrGd2-6, LcrGpS, LcrGpI and LcrGpSI proteins. Whole cell lysates from ΔlcrG3 Y. pestis transcomplemented with LcrGd2-6, LcrGpS, LcrGpI or LcrGpSI were separated by SDS-PAGE and immunoblotted with LcrG specific antiserum (α-LcrG) to visualize LcrG expression by the transcomplemented ΔlcrG3 Y. pestis strains (Fig. 2A). ΔlcrG3 Y. pestis strains transcomplemented with mutant LcrGs (LcrGd2-6, and LcrGpI) expressed LcrG at or near wildtype levels (Fig. 2B) demonstrating stable expression of LcrGd2-6 and LcrGpI. LcrGpS and LcrGpSI were weakly expressed (Fig. 2A; LcrG is barely visible in lanes 13, 14, 17 and 18). Immunoblots probed with α-LcrG from culture supernatants of ΔlcrG3 Y. pestis grown in the presence or absence of Ca2+ demonstrated that LcrGpI was not detected in the culture supernatants (Fig. 2B) (some higher molecular bands are apparent in lane 16 (Fig. 2B) these are cross-reactive bands from the LcrV antisera that was used as a secretion control along with the LcrG antisera) suggesting that LcrGpI was not secreted. LcrGd2-6 was detected in the culture supernatant (Fig. 2B) demonstrating that amino acids 2–6 for LcrG are not required for LcrG secretion. LcrGpS and LcrGpSI were too weakly expressed for their secretion to be determined (Fig 2). The LcrG secretion results with LcrGd2-6, LcrGpS, LcrGpI and LcrGpSI suggest that amino acids 2–6 are not required for LcrG secretion. However, the composition of acids 2–6 of LcrG did affect LcrG secretion. Taken together, results with the LcrG GAL4AD chimeras and the N-terminal LcrG mutants support the hypothesis that LcrG secretion is not necessary for LcrG function. The results with LcrGpI provide the strongest evidence that LcrG secretion is not required for LcrG function as LcrGpI is expressed above wildtype levels (Fig. 2A; compare lanes 15–16 with lanes 1–2) and LcrGpI was not secreted unlike the case of the ΔlcrG3 strain transcomplemented with LcrG (Fig. 2B) where LcrG is well expressed and easily detected in culture supernatants. In this manuscript, LcrG secretion by wildtype Y. pestis was detectable. However, LcrG secretion has been variably observed [4] and the current results are consistent with previous studies on LcrG function in Y. pestis [2, 4, 6, 18, 26]. However, this variable LcrG secretion does questions whether LcrG is specifically secreted. To better define if LcrG is specifically secreted the presence of two known cytosolic proteins were examined. Whole cell fractions and culture supernatants were probed with antisera specific for the cytosolic chaperones LcrH and SycN (Fig. 2). Neither chaperone was secreted (Fig. 2B) consistent with the known behavior of T3SS chaperones. This result confirms that the presence of LcrG in culture supernatants is likely due to the action of the Yersinia T3SS and is not due to cell lysis during culture. Additionally the ability of the LcrG-GAL4AD chimera to be secreted and the disruption of LcrG secretion by mutation also suggest that LcrG is a T3SS substrate.

The LcrG-GAL4 chimeras and the LcrG mutant proteins were also tested for the ability to support translocation of Yops into HeLa cells. Wildtype Y. pestis, ΔlcrG3 Y. pestis and ΔlcrG3 Y. pestis transcomplemented with GAL4AD-LcrG, LcrG-Gal4AD, LcrGd2-6, LcrGpS, LcrGpI or LcrGpSI all were tested for Yops translocation by examining HeLa cells infected with the various constructs. Infection of HeLa cells with yersiniae and examination of the cultured cells for cell 'rounding' has proven to be a very reliable indicator of Yops translocation [26, 27]. The ΔlcrG3 Y. pestis strain transcomplemented with the mutant LcrG proteins (GAL4AD-LcrG, LcrG-Gal4AD, LcrGd2-6, LcrGpS, LcrGpI and LcrGpSI) or with vector alone were normal for Yops translocation (Fig. 3) compared to the wildtype Y. pestis strain (Fig. 3) after 3 h of contact. The ability of the mutant and chimeric LcrG proteins (GAL4AD-LcrG, LcrG-Gal4AD, LcrGd2-6, LcrGpS, LcrGpI and LcrGpSI) to support LcrG function both in vitro and in tissue culture demonstrates that the mutant LcrG proteins are functional to support Yops secretion regulation and the known enhancement of Yops translocation by LcrG [19]. Importantly for this study, mutant and chimeric LcrG proteins are functional to support Yops secretion and translocation even though LcrG secretion by ΔlcrG3 Y. pestis strains transcomplemented with LcrGpI is not observable, suggesting that LcrG secretion is not required to support translocation. To confirm the results with HeLa cell cytotoxicity, the ability of the ΔlcrG3 strains transcomplemented with wildtype and mutant LcrG proteins (GAL4AD-LcrG, LcrG-Gal4AD, LcrGd2-6, LcrGpS, LcrGpI and LcrGpSI) to translocate YopN was analyzed using a YopN-GSK construct that is phosphorylated only after translocation into the eukaryotic cell cytoplasm [28]. All of the mutant LcrG proteins supported translocation of YopN-GSK (Fig. 4) demonstrated by the appearance of PO4-YopN-GSK in the assay. Based on the intensities of the bands in Fig. 4, no significant differences in translocation efficiency are apparent.

Figure 3
figure3

HeLa cell infections by Y. pestis Δ lcrG3 with LcrG chimeras and N-terminal LcrG mutants. HeLa cells were infected at an MOI of 30. Images were captured 3 hours post infection on an Olympus IX50 inverted microscope fitted with a Nikon D70 digital camera (magnification 400×) to document cell cytotoxcity.

Full size image
Figure 4
figure4

Expression and translocation of YopN-GSK. Translocation and phosphorylation of YopN-GSK in infected HeLa cells. Infected HeLa cell monolayers were solubilized with SDS-PAGE sample buffer and analyzed by SDS-PAGE in a 12.5% polyacrylamide gel and immunoblotted. Immunoblots were probed with phospho-GSK-3β antibodies that detect the GSK tag only when phosphorylated and α-YopN antibodies. Proteins were visualized by probing with alkaline phosphatase conjugated secondary antibodies and developed with NBT-BCIP.

Full size image

The results presented in this study demonstrate that LcrG secretion is signaled at least in part by information in the N-terminus of LcrG as evidenced by the inability of the LcrGpI mutant to be secreted. This work is consistent with the observation of Lloyd et al. that poly-I can block secretion of T3SS substrates in the yersiniae [11]. However, since the LcrG Δ2–6 mutant could also be secreted, our results suggest that other information is retained in the LcrG Δ2–6 protein or in lcrG that guides LcrG into the T3SS. The results presented in this manuscript suggest that while LcrG is a substrate of the T3SS in Y. pestis, the ability of LcrG to be secreted by the T3SS is irrelevant to LcrG function.

Conclusion

In this study, the relevance of LcrG secretion by the Ysc T3SS was examined. We found that LcrG could function after construction of LcrG and GAL4AD chimeric proteins, this was likely due to proteolytic release of LcrG from the chimera. However, those results prompted a deeper examination of LcrG secretion by the Ysc T3SS. In agreement with previous work [2] LcrG was found to be secreted by the Ysc T3SS in Y. pestis. Subsequent site directed mutagenesis of the putative T3S-signal in the N-terminus of LcrG resulted in LcrG mutants that were functional in Yops-secretion regulation and one stable LcrG mutant that not was secreted. The discovery of an LcrG mutant that was functional but not secreted suggests LcrG secretion while mediated by the Ysc T3SS is not necessary for LcrG function.

Methods

Bacterial strains and plasmids

The bacterial strains used in this study are listed in Table 1. Y. pestis was grown in heart infusion broth (HIB, Difco, Detroit MI) or on tryptose blood agar base (TBA, Difco) plates at 26°C for genetic manipulations. Escherichia coli strains were grown in Luria-Bertani broth (Difco) or on TBA plates at 37°C. When appropriate, bacteria were grown in the presence of carbenicillin at a concentration of 50 μg/ml.

Table 1 Strains and plasmids used in this study
Full size table

DNA techniques and plasmid constructions

Cloning methods were performed as described previously [29]. PCR fragments were purified using the QiaQuick PCR purification kit (Qiagen, Valencia, CA). Transformation of DNA into E. coli was accomplished by using commercially obtained competent cells (Novablue, Novagen, Madison, Wis.). Electroporation of DNA into Y. pestis cells was done as described previously [4]. Gene amplification was performed with Deep Vent (New England Biolabs, Beverly, Mass.) or Taq DNA polymerase (Eppendorf Scientific, Westbury, N.Y.). Plasmids used in this study are described in Table 1. Chimeric LcrG proteins were created by fusing the GAL4 activation domain (GAL4AD) to the N- or C-terminus of LcrG [6]. pLR01 (LcrG-Gal4) was constructed by amplifying LcrG with primers AraG-start (5' GGA ATT CAG GAG GAA AGG TCT TCC CAT TTG GAT 3') and AraG-back (5' CGC GGA TCC AAT ATT TTG CAT CAT CG 3'). The amplified sequences were digested with Eco RI and ligated into Eco RI- and Sma I-cleaved pBAD18. Gal4AD was amplified with primers described by Matson and Nilles [6]. Plasmids pLR02, pLR03, pLR04 and pLR05 were constructed by performing site-directed mutagenesis on pAraG18 [26]. Substitution mutations or deletion of amino acids (aa) 2–6 in the N-terminus of LcrG were constructed as indicated in Table 1. Site-directed mutagenesis was performed with Pfu Turbo DNA polymerase (Stratagene, La Jolla, Calif.) using the QuickChange Site-directed Mutagenesis Kit (Stratagene) according to the manufacturer's instructions. Oligonucleotide primers were synthesized by MWG Biotech (High Point, N.C.). Complementary oligonucleotides were designed to contain the desired mutation, flanked by unmodified sequence to anneal to the same sequence on opposite strands of the template plasmid. All mutations were confirmed by sequencing.

Media and growth conditions

Plasmids expressing LcrG, LcrG with substitution mutations/deletions of aa 2–6, or the LcrG-GAL4 chimeras were introduced into the ΔlcrG 3 mutant strain KIM8.3002-7 [19] and cultures were grown in TMH (a chemically defined medium) [30] with or without calcium. The cultures were shifted to 37°C and arabinose (0.2% w/v) was added at the same time to induce expression of LcrG from the vectors. After 4 hours of growth at 37°C, samples from the cultures were harvested and separated into whole-cell and cell-free culture supernatants as described previously [4]. Both fractions were analyzed by immunoblotting to assess protein expression and by immunoblotting or silver staining (Silver Snap II, Pierce, Rockford, IL) to assess protein secretion.

Protein electrophoresis and immunodetection

Fractions corresponding to 0.05 A620·ml of bacterial whole cell or culture supernatants prepared in 2 × SDS-PAGE sample buffer were loaded for all protein samples. Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) according to the method described by Laemmli [31]. Proteins resolved by SDS-PAGE were silver stained or transferred to Immobilon-P membranes (Millipore Corp., Bedford, Mass.) using carbonate transfer buffer (pH 9.9) [2] for immunoblotting. Specific proteins were visualized using rabbit polyclonal antibodies specific for LcrG (α-LcrG [4]), YopB (α-YopB), YopD (α-YopD [32]), YopE (α-YopE), LcrV (α-LcrV [4]), YopN (α-YopN [33]), SycN (α-SycN [34]) and LcrH (α-LcrH [35]) as primary antibodies and alkaline-phosphatase conjugated secondary antibodies followed by development with 5-bromo-4-chloro-3-indolylphosphate/nitroblue tetrazolium NBT-BCIP [36]. Conditions used for immunodetection were the same for whole cell and supernatant fractions.

HeLa cell infections

Yop translocation was monitored visually by cytotoxicity (cells rounding up) with cultured HeLa cells grown in Dulbecco's Modified Eagle Minimum essential medium (D-MEM) supplemented with 10% fetal calf serum (FCS, Invitrogen, Carlsbad, CA), penicillin, pyruvate and glutamine and grown at 37°C in a 5% CO2 atmosphere. HeLa cells were seeded into 24-well tissue culture plates (105 cells/well) and after the HeLa cells reached near confluency the growth medium was removed and the cells washed twice with L15 medium and placed in L15 for infection [26]. Next 30 μl of 105 CFU/μL of bacteria were added (MOI:30). The plates were centrifuged for 5 minutes at 25°C (300 × g) to allow cell contact. The plates were incubated at 37°C for 2–6 hours to check for cytotoxicity and photographed at 3 h.

GSK phosphorylation to monitor translocation

Y. pestis strains carrying a pBAD33 derivative expressing YopN-GSK [28] were pre-induced with L-arabinose (0.2% w/v) for 1 h prior to infection and 0.2% arabinose (w/v) was maintained during the infection. HeLa cell monolayers were infected with Y. pestis strains at a multiplicity of infection (MOI) of 30 for 3 h at 37°C in L15 medium as described previously [6]. After 3 h, culture supernatants were decanted and the infected HeLa cells were lysed by the addition of 100 μl of 2 × SDS-PAGE lysis buffer containing mammalian cell protease (P-8340) and phosphatase (P-2850) inhibitor cocktails (Sigma). Samples were boiled for 5 min and analyzed by SDS-PAGE and separate identical immunoblots were probed with a GSK-3β (not shown; no. 9332, Cell Signaling Technology), a phosphospecific GSK-3β (no. 9336, Cell Signaling Technology) or an α-YopN antibody preparation. Secondary antibody (alkaline phosphatase-conjugated anti-rabbit immunoglobulin G) was diluted in TTBS containing 5% nonfat milk and 0.05% Tween 20 and incubated with the blots for 2 h. Blots were washed three times for five minutes and developed with BCIP-NBT.

Image acquisition and production

All immnunoblots were scanned on an Epson 4490 Perfection scanner at 4800 dpi using VueScan software (v. 8.4.40; Hamrick Software, [37]). Micrographs were captured on a Nikon D70 digital camera in NEF format. The scanned blots and micrographs were imported into Adobe Photoshop (CS3, Adobe Software, San Jose, CA) the images were converted to grayscale and the auto levels function was applied. Final figures were assembled in Adobe Illustrator (CS3) and images were downsampled to the final resolution upon export to the PNG file format.

References

  1. 1.

    Perry RD, Fetherson JD: Yersinia pestis – etiologic agent of plague. Clin Microbiol Rev. 1997, 10: 35-66.

  2. 2.

    Skrzypek E, Straley SC: LcrG, a secreted protein involved in negative regulation of the low-calcium response in Yersinia pestis. J Bacteriol. 1993, 175: 3520-3528.

  3. 3.

    Straley SC, Perry RD: Environmental modulation of gene expression and pathogenesis in Yersinia. Trends Microbiol. 1995, 3 (8): 310-317. 10.1016/S0966-842X(00)88960-X.

  4. 4.

    Nilles ML, Williams AW, Skrzypek E, Straley SC: Yersinia pestis LcrV forms a stable complex with LcrG and may have a secretion-related regulatory role in the low-Ca2+ response. J Bacteriol. 1997, 179: 1307-1316.

  5. 5.

    Lawton DG, Longstaff C, Wallace BA, Hill J, Leary SE, Titball RW, Brown KA: Interactions of the type III secretion pathway proteins LcrV and LcrG from Yersinia pestis are mediated by coiled-coil domains. J Biol Chem. 2002, 277 (41): 38714-38722. 10.1074/jbc.M203632200.

  6. 6.

    Matson JS, Nilles ML: LcrG-LcrV Interaction Is Required for Control of Yops Secretion in Yersinia pestis. J Bacteriol. 2001, 183 (17): 5082-5091. 10.1128/JB.183.17.5082-5091.2001.

  7. 7.

    Cornelis GR: Type III secretion: a bacterial device for close combat with cells of their eukaryotic host. Philos Trans R Soc Lond B Biol Sci. 2000, 355 (1397): 681-693. 10.1098/rstb.2000.0608.

  8. 8.

    Cornelis GR: The Yersinia Ysc-Yop 'type III' weaponry. Nat Rev Mol Cell Biol. 2002, 3 (10): 742-752. 10.1038/nrm932.

  9. 9.

    Lloyd SA, Forsberg A, Wolf-Watz H, Francis MS: Targeting exported substrates to the Yersinia TTSS: different functions for different signals?. Trends Microbiol. 2001, 9 (8): 367-371. 10.1016/S0966-842X(01)02100-X.

  10. 10.

    Lloyd SA, Norman M, Rosqvist R, Wolf-Watz H: Yersinia YopE is targeted for type III secretion by N-terminal, not mRNA, signals. Mol Microbiol. 2001, 39 (2): 520-532. 10.1046/j.1365-2958.2001.02271.x.

  11. 11.

    Lloyd SA, Sjostrom M, Andersson S, Wolf-Watz H: Molecular characterization of type III secretion signals via analysis of synthetic N-terminal amino acid sequences. Mol Microbiol. 2002, 43 (1): 51-59. 10.1046/j.1365-2958.2002.02738.x.

  12. 12.

    Bronstein PA, Miao EA, Miller SI: InvB is a type III secretion chaperone specific for SspA. J Bacteriol. 2000, 182 (23): 6638-6644. 10.1128/JB.182.23.6638-6644.2000.

  13. 13.

    Ghosh P: Process of protein transport by the type III secretion system. Microbiol Mol Biol Rev. 2004, 68 (4): 771-795. 10.1128/MMBR.68.4.771-795.2004.

  14. 14.

    Guttman DS, Vinatzer BA, Sarkar SF, Ranall MV, Kettler G, Greenberg JT: A functional screen for the type III (Hrp) secretome of the plant pathogen Pseudomonas syringae. Science. 2002, 295 (5560): 1722-1726. 10.1126/science.295.5560.1722.

  15. 15.

    Anderson DM, Schneewind O: A mRNA signal for the type III secretion of Yop proteins by Yersinia enterocolitica. Science. 1997, 278 (5340): 1140-1143. 10.1126/science.278.5340.1140.

  16. 16.

    Keegan L, Gill G, Ptashne M: Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. Science. 1986, 231 (4739): 699-704. 10.1126/science.3080805.

  17. 17.

    DeBord KL, Lee VT, Schneewind O: Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica. J Bacteriol. 2001, 183 (15): 4588-4598. 10.1128/JB.183.15.4588-4598.2001.

  18. 18.

    Matson JS, Nilles ML: Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface. BMC Microbiol. 2002, 2 (1): 16-10.1186/1471-2180-2-16.

  19. 19.

    Fields KA, Nilles ML, Cowan C, Straley SC: Virulence role of V antigen of Yersinia pestis at the bacterial surface. Infect Immun. 1999, 67 (10): 5395-5408.

  20. 20.

    Feldman MF, Muller S, Wuest E, Cornelis GR: SycE allows secretion of YopE-DHFR hybrids by the Yersinia enterocolitica type III Ysc system. Mol Microbiol. 2002, 46 (4): 1183-1197. 10.1046/j.1365-2958.2002.03241.x.

  21. 21.

    Jacobi CA, Roggenkamp A, Rakin A, Zumbihi R, Leitritz L, Heesemann J: In vitro and in vivo expression studies of yopE from Yersinia enterocolitica using the gfp reporter gene. Mol Microbiol. 1998, 30: 865-882. 10.1046/j.1365-2958.1998.01128.x.

  22. 22.

    Sory M-P, Cornelis GR: Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol Microbiol. 1994, 14: 583-594. 10.1111/j.1365-2958.1994.tb02191.x.

  23. 23.

    Sory MP, Boland A, Lambermont I, Cornelis GR: Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach. Proc Natl Acad Sci USA. 1995, 92 (26): 11998-12002. 10.1073/pnas.92.26.11998.

  24. 24.

    Sorg JA, Miller NC, Marketon MM, Schneewind O: Rejection of impassable substrates by Yersinia type III secretion machines. J Bacteriol. 2005, 187 (20): 7090-7102. 10.1128/JB.187.20.7090-7102.2005.

  25. 25.

    Sorg JA, Miller NC, Schneewind O: Substrate recognition of type III secretion machines – testing the RNA signal hypothesis. Cell Microbiol. 2005, 7 (9): 1217-1225. 10.1111/j.1462-5822.2005.00563.x.

  26. 26.

    Nilles ML, Fields KA, Straley SC: The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG. J Bacteriol. 1998, 180 (13): 3410-3420.

  27. 27.

    Cornelis GR, Wolf-Watz H: The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol. 1997, 23: 861-867. 10.1046/j.1365-2958.1997.2731623.x.

  28. 28.

    Garcia JT, Ferracci F, Jackson MW, Joseph SS, Pattis I, Plano LR, Fischer W, Plano GV: Measurement of effector protein injection by type III and type IV secretion systems by using a 13-residue phosphorylatable glycogen synthase kinase tag. Infect Immun. 2006, 74 (10): 5645-5657. 10.1128/IAI.00690-06.

  29. 29.

    Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. 1989, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, Second

  30. 30.

    Straley SC, Bowmer WS: Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun. 1986, 51: 445-454.

  31. 31.

    Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-685. 10.1038/227680a0.

  32. 32.

    Williams AW, Straley SC: YopD of Yersinia pestis plays a role in the negative regulation of the low-calcium response in addition to its role in the translocation of Yops. J Bacteriol. 1998, 180: 350-358.

  33. 33.

    Jackson MW, Day JB, Plano GV: YscB of Yersinia pestis functions as a specific chaperone for YopN. J Bacteriol. 1998, 180 (18): 4912-4921.

  34. 34.

    Day JB, Plano GV: A complex composed of SycN and YscB functions as a specific chaperone for YopN in Yersinia pestis. Mol Microbiol. 1998, 30 (4): 777-788. 10.1046/j.1365-2958.1998.01110.x.

  35. 35.

    Skrzypek E, Straley SC: Differential effects of deletions in lcrV on secretion of V antigen, regulation of the low-Ca2+ response, and virulence of Yersinia pestis. J Bacteriol. 1995, 177: 2530-2542.

  36. 36.

    Coligan JE, Dunn BM, Speicher DW, Wingfield PT, (eds): Current protocols in protein science. 1998, New York: John Wiley & Sons

  37. 37.

    [http://www.hamrick.com]

  38. 38.

    Guzman L-M, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol. 1995, 177: 4121-4130.

Download references

Acknowledgements

The authors thank Susan Straley (University of Kentucky, Lexington KY) for the gift of α-YopE, α-YopD and α-LcrH. James Bliska (SUNY Stonybrook, Stonybrook, NY) for α-YopB. Greg Plano (Univ. of Miami, Miami, FL) for α-YopN, α-SycN and pBAD33-YopN-GSK. This work was supported by grant AI051520 from NIAID.

Author information

Affiliations

  1. Department of Microbiology and Immunology, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, ND, 58202, USA

    • Laura D Reina
    • , Deanna M O'Bryant
    • , Jyl S Matson
    •  & Matthew L Nilles

  2. Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, 48109-0620, USA

    • Jyl S Matson

Authors

  1. Search for Laura D Reina in:

  2. Search for Deanna M O'Bryant in:

  3. Search for Jyl S Matson in:

  4. Search for Matthew L Nilles in:

Corresponding author

Correspondence to Matthew L Nilles.

Additional information

Authors' contributions

JSM performed the initial studies with GAL4AD-LcrG, LDR performed subsequent experiments and wrote the draft of the manuscript, DMO performed the final experiments in the manuscript. MLN conceived of the study, supervised the work and edited the manuscript. All authors read and approved the final manuscript.

Authors’ original submitted files for images

Authors’ original file for figure 1

Authors’ original file for figure 2

Authors’ original file for figure 3

Authors’ original file for figure 4

Rights and permissions

Reprints and Permissions

About this article

Keywords

  • HeLa Cell
  • Yersinia Pestis
  • GAL4 Activation Domain
  • Pestis Strain
  • Yops Secretion

BMC Microbiology

ISSN: 1471-2180

Contact us